Exploring the Role of Autophagy in Alzheimer's Disease
Written on
Chapter 1: Understanding Neurodegenerative Disorders
As we age, our bodies naturally undergo degeneration, leading to a variety of degenerative disorders, particularly those affecting the brain. Alzheimer’s disease, along with Parkinson’s and Huntington’s diseases, impacts millions globally.
By 2016, it was estimated that around 5 million people were living with Alzheimer’s, a figure projected to rise to 80 million by 2040.
Alzheimer's Disease Overview
Alzheimer's disease is a progressive and irreversible brain condition that gradually impairs memory and cognitive abilities. It is a major contributor to dementia, marked by a decline in memory, reasoning, and other cognitive functions. As the condition advances, individuals may lose most of their memories and require significant assistance for daily tasks, including speaking and walking. Currently, early diagnosis remains challenging, and no definitive cures exist.
Until we can effectively combat aging, we must find ways to manage these debilitating disorders. Recent studies are exploring autophagy as a potential target for treating degenerative diseases.
The first video, "Dementia could start in your blood vessels - eat these foods to keep your mind sharp | Dr William Li," discusses dietary interventions that may support cognitive health.
Chapter 2: The Mechanism of Autophagy
Autophagy, which translates to "self-eating," is a vital cellular process wherein a cell consumes parts of itself. This can be triggered by various internal and external factors. The accumulation of damaged organelles or abnormal proteins prompts autophagy. If these abnormal protein aggregates are not removed, they can lead to neuronal degeneration and ultimately the death of brain cells. Such aggregates are closely linked to Alzheimer’s and other neurodegenerative conditions, although the precise role of autophagy in Alzheimer’s pathology is still under investigation.
Research indicates that autophagy is often disrupted in neurons of Alzheimer’s patients. This raises the question: Could impaired autophagy be a contributing factor to Alzheimer’s? Is it possible that enhancing autophagy could help eliminate protein aggregates and potentially reverse the disease?
Autophagy and Degenerative Disorders
Autophagy is crucial for normal cellular operations, yet it can malfunction, potentially serving as both a concurrent issue and a precursor to various diseases. A reduction in autophagic activity may hinder the ability of neurons to clear harmful protein aggregates.
Existing medications, such as rapamycin and metformin, have been shown to enhance autophagy, leading to improved motor function in animal studies of Huntington’s and Alzheimer’s diseases. Notably, metformin has demonstrated cognitive benefits in older adults (average age over 69) in a Phase 2 clinical trial, with further studies underway to explore its effects on age-related neurodegeneration.
The second video, "Biological basis of Alzheimer's disease," delves into the underlying mechanisms of this complex condition.
Innovations in Autophagy Research
Numerous innovative startups are focusing on autophagy as a potential treatment avenue for various degenerative disorders. For instance, Casma Therapeutics is working to identify the drivers of autophagy to stimulate the clearing of dysfunctional protein aggregates. Their efforts extend beyond neurodegeneration, also encompassing conditions like muscular dystrophy and liver diseases.
Samsara Therapeutics is taking a holistic approach to promote healthy aging, exploring compounds that can enhance autophagy. Meanwhile, Caraway Therapeutics is utilizing neurons derived from patients to uncover causes of dysfunctional autophagy, serving as a more accurate model for drug testing compared to traditional methods. They are also developing mini-brains using patient-derived neurons for drug discovery.
Casma Therapeutics has secured a $370,000 grant from the Michael J. Fox Foundation to advance their research on neuronal autophagy-promoting drugs, alongside a significant $58.5 million investment from Third Rock Ventures. Caraway has also attracted $23 million from various investors.
As we move forward, only time will reveal the effectiveness of these startups in combating Alzheimer’s. The quest for a cure remains critical, as overcoming this disease could significantly enhance the quality of life for the elderly.
Regulating autophagy may hold the key to addressing neurodegeneration in the future. While the connection between autophagy and neurodegeneration is still being clarified, it offers a glimmer of hope.
> "When autophagy is more active, it is likely to make cells healthier." — Dr. Nicholas Ktistakis, Scientist, Babraham Institute, UK.